The primary completion date for 202 is Jan 31 so the 6-month info from the last (and the tenth) patient has been collected latest on the 31st of July. So it is very likely that Claassen can present the main 6-month results of the 202 study ( which were not ready in the middle of July) and a few more 1-year follow-ups. New, unpublished data needs to be available and the company wants to present them as a late-breaking talk and poster.
What would be breaking news?
We know that 3 of seven were responders, 3 of 10 would not be breaking news, and equally, 4 of 10 (?) but 5 of 10 would be.
There are also new 1-year follow-ups. Perhaps the breaking news is dealing with brain volume.
ATH Price at posting:
0.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)